GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules, 120 mg and 240 mg07-10-2020
07-10-2020
GLENMARK PHARMACEUTICALS LTD. - 532296 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HSBC Global Asset Management (Hong Kong) Ltd06-10-2020
GLENMARK PHARMACEUTICALS LTD. - 532296 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Glenmark Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here30-09-2020
GLENMARK PHARMACEUTICALS LTD. - 532296 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Proceedings and Scrutinizer''s Report of the 42nd Annual General Meeting of Glenmark Pharmaceuticals Limited held on September 29, 202029-09-2020
GLENMARK PHARMACEUTICALS LTD. - 532296 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings and Scrutinizer''s Report of the 42nd Annual General Meeting of Glenmark Pharmaceuticals Limited held on September 29, 202029-09-2020
Higher sales in domestic market, lower costs bode well for Glenmark
The other trigger for the stock is the cost savings from lower investments in R&D and fund raising for innovation research21-09-2020
Glenmark: Domestic sales performance, lower costs bode well for the stock
Funding for its innovation subsidiary is a key trigger14-09-2020
Quant Pick - Glenmark Pharma: ICICI Direct
According to ICICI Direct, The pharma space has shown significant resilience in the last couple of weeks amid broader market volatility.11-09-2020
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement of Notice of 42nd Annual General Meeting (AGM), E-voting Information and Book Closure07-09-2020
GLENMARK PHARMACEUTICALS LTD. - 532296 - Reg. 34 (1) Annual Report
Submission of Annual Report under Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201504-09-2020